Concepedia

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

Chris H. Polman, Antonio Bertolotto, Florian Deisenhammer, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer, Joep Killestein, Henry F. McFarland, Joël Oger, Andrew R. Pachner,

The Lancet Neurology · 2010 · 199 citations · 66 references

DOI

Concepts

References

66

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

Neurology · 1993 · 2.1K citations

, , +14

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

George C. Ebers · The Lancet · 1998 · 2.1K citations

, , +8

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

D. W. Paty, D.K.B. Li · Neurology · 1993 · 2K citations · Full text

, , +14

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

Marc Girard, Pierre Duquette, W. A. Sibley · 1993 · 1.2K citations

, , +10

Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis

Ludwig Kappos · The Lancet · 1998 · 944 citations · Full text

, , +8